Skip to main content
A farewell to arms? Drug approvals based on single-arm trials can be flawed
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
A farewell to arms? Drug approvals based on single-arm trials can be flawed
User login
Username
Password
Reset your password
Concept
Lead
score
Patient Safety
1
0.8
Hepatocellular Carcinoma
0
0.96
Lung Cancer
0
0.7
Cancer
0
0.65
Healthcare and Medical Technology
0
0.63
Clinical Research
0
0.54
Small Cell Lung Cancer
0
0.44
Tumor
0
0.43
Desmoid Tumor
0
0.38
Europe
0
0.32
Grant
0
0.22
Drug and Treatment Safety
0
0.11
Lung
0
0.11
Medical Oncology
0
0.11
Orbit
0
0.11
Quality of Life
0
0.11
Rare Diseases
0
0.11
Refractory
0
0.11
Transplant Evaluation
0
0.11
Specialty
Lead
score
Hematology-Oncology
1
1
Gastroenterology
0
0.96
Pulmonary Medicine
0
0.7
Dermatology
0
0.66
Internal Medicine
0
0.62
Pharmacist
0
0.57
Transplantation
0
0.13
Edit Tags